Physician profile
Klive M Forde
NPI 1629331772
$1,070.51
in general payments reported to CMS, 2019-2025
12 companies · $13.69 in 2025
The $13.69 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $103 · 2021: $527 · 2022: $154 · 2023: $49.95 · 2024: $21.77 · 2025: $13.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $85.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $85.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $273.05 | 2019-2022 | |
| Viiv Healthcare Company | $204.55 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $161.89 | 2021-2022 | |
| Novo Nordisk INC | $127.08 | 2020-2024 | Rybelsus, Ozempic |
| Abbvie INC. | $93.84 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $85.52 | 2019-2022 | |
| Amgen INC. | $46.62 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $21.63 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.36 | 2019 | |
| Coopersurgical, INC. | $13.69 | 2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $13.65 | 2021 | |
| Melinta Therapeutics, LLC | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Klive Forde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.